BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23255092)

  • 1. Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment.
    Ma W; Ma J; Xu J; Qiao C; Branscum A; Cardenas A; Baron AT; Schwartz P; Maihle NJ; Huang Y
    Cell Cycle; 2013 Jan; 12(1):88-97. PubMed ID: 23255092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMPs morph into new roles in ovarian cancer.
    McLean K; Buckanovich RJ
    Cell Cycle; 2013 Feb; 12(3):389. PubMed ID: 23324340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer.
    Peng S; Maihle NJ; Huang Y
    Oncogene; 2010 Apr; 29(14):2153-9. PubMed ID: 20101213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells.
    Qiu C; Ma Y; Wang J; Peng S; Huang Y
    Nucleic Acids Res; 2010 Mar; 38(4):1240-8. PubMed ID: 19966271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop.
    Coffman LG; Choi YJ; McLean K; Allen BL; di Magliano MP; Buckanovich RJ
    Oncotarget; 2016 Feb; 7(6):6916-32. PubMed ID: 26755648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
    Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
    Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer.
    Guo D; Huang J; Gong J
    Mol Cell Biochem; 2012 Apr; 363(1-2):179-90. PubMed ID: 22167620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
    Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
    Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD166 promotes the cancer stem-like properties of primary epithelial ovarian cancer cells.
    Kim DK; Ham MH; Lee SY; Shin MJ; Kim YE; Song P; Suh DS; Kim JH
    BMB Rep; 2020 Dec; 53(12):622-627. PubMed ID: 32843129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
    Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
    Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
    Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
    Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
    Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
    Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meiotic competent human germ cell-like cells derived from human embryonic stem cells induced by BMP4/WNT3A signaling and OCT4/EpCAM (epithelial cell adhesion molecule) selection.
    Chuang CY; Lin KI; Hsiao M; Stone L; Chen HF; Huang YH; Lin SP; Ho HN; Kuo HC
    J Biol Chem; 2012 Apr; 287(18):14389-401. PubMed ID: 22396540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: A new regulatory mechanism for cancer stem cell formation.
    Maiuthed A; Bhummaphan N; Luanpitpong S; Mutirangura A; Aporntewan C; Meeprasert A; Rungrotmongkol T; Rojanasakul Y; Chanvorachote P
    J Biol Chem; 2018 Aug; 293(35):13534-13552. PubMed ID: 29986880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
    Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
    Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer.
    Bindhya S; Sidhanth C; Krishnapriya S; Garg M; Ganesan TS
    Int J Biochem Cell Biol; 2021 Sep; 138():106051. PubMed ID: 34343671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new signaling cascade linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcome.
    Voeltzel T; Flores-Violante M; Zylbersztejn F; Lefort S; Billandon M; Jeanpierre S; Joly S; Fossard G; Milenkov M; Mazurier F; Nehme A; Belhabri A; Paubelle E; Thomas X; Michallet M; Louache F; Nicolini FE; Caron de Fromentel C; Maguer-Satta V
    Cell Death Dis; 2018 Sep; 9(10):1011. PubMed ID: 30262802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.